This result again confirms the critical role played by GSTO1-1 in pro-inflammatory signaling and suggests the possibility that GSTO1-1 inhibitors may be of value in the treatment of T2D since IL-1β inhibitors have already been found to be effective in modulating insulin resistance38,39. Here, IL1B is linked to type 2 diabetes mellitus.